These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11780898)

  • 1. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease.
    Nakao N; Kakishita K; Uematsu Y; Yoshimasu T; Bessho T; Nakai K; Naito Y; Itakura T
    J Neurosurg; 2001 Aug; 95(2):275-84. PubMed ID: 11780898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study.
    Watts RL; Subramanian T; Freeman A; Goetz CG; Penn RD; Stebbins GT; Kordower JH; Bakay RA
    Exp Neurol; 1997 Oct; 147(2):510-7. PubMed ID: 9344575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell transplantation therapy for Parkinson's disease].
    Nakao N; Uematsu Y; Itakura T
    Nihon Rinsho; 2000 Oct; 58(10):2084-90. PubMed ID: 11068451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease.
    Fernandez-Espejo E; Armengol JA; Flores JA; Galan-Rodriguez B; Ramiro S
    Brain Res Brain Res Rev; 2005 Sep; 49(2):343-54. PubMed ID: 16111561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
    Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks DJ; Marsden CD; Oertel WH; Quinn NP; Rehncrona S; Lindvall O
    Brain; 2000 Jul; 123 ( Pt 7)():1380-90. PubMed ID: 10869050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases.
    Itakura T; Uematsu Y; Nakao N; Nakai E; Nakai K
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):112-5. PubMed ID: 9711742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.
    Freed CR; Breeze RE; Rosenberg NL; Schneck SA; Kriek E; Qi JX; Lone T; Zhang YB; Snyder JA; Wells TH
    N Engl J Med; 1992 Nov; 327(22):1549-55. PubMed ID: 1435881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.
    Lindvall O; Widner H; Rehncrona S; Brundin P; Odin P; Gustavii B; Frackowiak R; Leenders KL; Sawle G; Rothwell JC
    Ann Neurol; 1992 Feb; 31(2):155-65. PubMed ID: 1575454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.
    Spencer DD; Robbins RJ; Naftolin F; Marek KL; Vollmer T; Leranth C; Roth RH; Price LH; Gjedde A; Bunney BS
    N Engl J Med; 1992 Nov; 327(22):1541-8. PubMed ID: 1435880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
    Mendez I; Dagher A; Hong M; Gaudet P; Weerasinghe S; McAlister V; King D; Desrosiers J; Darvesh S; Acorn T; Robertson H
    J Neurosurg; 2002 Mar; 96(3):589-96. PubMed ID: 11883846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group.
    López-Lozano JJ; Bravo G; Brera B; Millán I; Dargallo J; Salmeán J; Uría J; Insausti J
    J Neurosurg; 1997 Jun; 86(6):931-42. PubMed ID: 9171171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamotomy for advanced Parkinson disease.
    Su PC; Tseng HM; Liu HM; Yen RF; Liou HH
    J Neurosurg; 2002 Sep; 97(3):598-606. PubMed ID: 12296644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
    Lindvall O; Sawle G; Widner H; Rothwell JC; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden CD; Odin P
    Ann Neurol; 1994 Feb; 35(2):172-80. PubMed ID: 8109898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restorative neurology in movement disorders.
    Hagell P
    J Neurosci Nurs; 2000 Oct; 32(5):256-62. PubMed ID: 11089197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.